Search This Blog

Friday, August 2, 2019

Deciphera Pharmaceuticals EPS beats by $0.53, beats on revenue

Deciphera Pharmaceuticals (NASDAQ:DCPH): Q2 GAAP EPS of -$0.56 beats by $0.53.
Revenue of $25M beats by $22.78M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)